Curaleaf Laboratories Launches First Certified Liquid Medical Cannabis Inhaler for UK Patients
The Curaleaf Que Medical Inhalation Device offers precise and consistent administration of cannabis-based medicines 1st September 2025 – Curaleaf Laboratories, part of Curaleaf International, today announced the UK launch of the Curaleaf Que Medical Inhalation Device (QMID), the first CE-certified liquid inhaler for cannabis-based medicines. Available on prescription, the device offers patients a precise, discreet, […]
Curaleaf Laboratories partners with Dalgety Ltd to distribute UK-grown EU-GMP medical cannabis flowers
Curaleaf Laboratories can today announce a partnership agreement has been reached with Dalgety Ltd, to exclusively manufacture and distribute medical cannabis API produced from their state-of-the-art cultivation facility in the UK. Dalgety, based in Derbyshire, are the first domestic cultivator of medical cannabis to hold EU-GMP licenses for the cultivation and supply of medical cannabis […]